Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $145

Benzinga · 3d ago
Cantor Fitzgerald analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $120 to $145.